Additionally, CgA showcases a greater utility in monitoring the progression of the disease and treatment response than as a diagnostic biomarker, as revealed by a 2018 meta-analysis on the subject, and increased values of CgA can predate radiological progression or tumor recurrence [30,31,32]. The gene discussed is CGA; the disease is neoplasm.